设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

2022 年第 3 期 第 17 卷

改善病情抗风湿药治疗病毒感染的机制及临床研究进展

Mechanism and clinical research progress of disease-modifying anti-rheumatic drugs in the treatment of viral infection

作者:焦桐陈昊杨静刘芮妮张舒恬吴沅皞

英文作者:Jiao Tong Chen Hao Yang Jing Liu Ruini Zhang Shutian Wu Yuanhao

单位:天津中医药大学第一附属医院风湿免疫科国家中医针灸临床医学研究中心天津市中医方证转化研究重点实验室,天津300380

英文单位:Department of Rheumatology and Immunology First Teaching Hospital of Tianjin University of Traditional Chinese Medicine National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion Key Laboratory of Translational Research of Traditional Chinese Medicine Prescription and Syndrome Tianjin 300380 China

关键词:改善病情抗风湿药;病毒;临床研究;新型冠状病毒肺炎

英文关键词:Disease-modifyinganti-rheumaticdrugs;Virus;Clinicalresearch;Coronavirusdisease-19

  • 摘要:
  • 改善病情抗风湿药(DMARDs)包括传统合成DMARDs、生物DMARDs和靶向合成DMARDs,近年来多项研究发现这一类药物也同样具有广泛的抗病毒作用,甚至具有治疗新型冠状病毒感染的可能。DMARDs通过多种复杂机制对病毒产生抑制作用,涉及了多个靶点和通路,如白细胞介素6 信号通路、氧化还原通路、JAK通路等,在治疗病毒感染方面具有非常广阔的前景,现有的研究拓展了DMARDs药物的应用范围,使其有望成为一类独特的抗病毒药物。

  • Disease-modifying anti-rheumatic drugs DMARDs include conventional synthesis DMARDs, biosynthesis DMARDs, and targeted synthesis DMARDs. In recent years, many studies have found that DMARDs have extensive antiviral effects, and even have the possibility for treating 2019 novel corona virus infection. DMARDs inhibit the virus through a variety of complex mechanisms, involving multiple targets and pathways, such as interleukin-6 signal pathway, redox pathway, JAK pathway and so on. DMARDs have a very broad prospect in the treatment of viral infection. Current research results expand the applicated scope of DMARDs, which are expected to become a kind of unique antiviral drugs.

copyright
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址: 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭
Baidu
map